|
||
|
FeRx Incorporated
Download PDF Members: The Company is focused on the development and commercialization of its proprietary Magnetic Targeted Carrier ("MTC") technology for the site specific delivery and sustained release of pharmaceutical agents. FeRx's lead compound, MTC-Doxorubicin, is in Phase I/II clinical trials in patients with liver cancer.
This page has been viewed 395 times since April 2007, the link to the organisation's website has been followed 100 times Recent Search Terms used to find this page: www.Ferx 6 .com | ferx incorporated | ferx san diego | FeRx | FeRx | www.ferx com. | FERX INCORPORATED | FeRx | FeRx Incorporated | FeRx chief scientific officer | . This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for FeRx Incorporated | ||||||||||||||||||||||||||||||||||||||||||||||
Nothing in this website should be used in place of personal medical
advice from your own qualified medical practitioner. See
User
Agreement |
All rights reserved. All other trademarks recognized. |
|
|